Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1995-1-12
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0165-6147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
320; author reply 321-2
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7992382-Animals,
pubmed-meshheading:7992382-Dose-Response Relationship, Drug,
pubmed-meshheading:7992382-Humans,
pubmed-meshheading:7992382-Pharmaceutical Preparations,
pubmed-meshheading:7992382-Pharmacology,
pubmed-meshheading:7992382-Radioligand Assay,
pubmed-meshheading:7992382-Receptors, Drug
|
pubmed:year |
1994
|
pubmed:articleTitle |
Problems associated with the partiality of a partial agonist.
|
pubmed:publicationType |
Letter,
Comment
|